24 ORAL Modulation of adjuvant 5-FU treatment by folinic acid and interferon-alpha in colon and rectal cancer: Comparison of two phase-III trials including 1652 patients

MLA

Doris Henne-Bruns, et al. “24 ORAL Modulation of Adjuvant 5-FU Treatment by Folinic Acid and Interferon-Alpha in Colon and Rectal Cancer: Comparison of Two Phase-III Trials Including 1652 Patients.” European Journal of Surgical Oncology (EJSO), vol. 32, Nov. 2006, pp. S8–9. EBSCOhost, https://doi.org/10.1016/s0748-7983(06)70459-0.

APA

Doris Henne-Bruns, K. H. Link, M. Redenbacher, Ludger Staib, Marko Kornmann, W. Baumann, & Silvia Sander. (2006). 24 ORAL Modulation of adjuvant 5-FU treatment by folinic acid and interferon-alpha in colon and rectal cancer: Comparison of two phase-III trials including 1652 patients. European Journal of Surgical Oncology (EJSO), 32, S8–S9. https://doi.org/10.1016/s0748-7983(06)70459-0

Chicago

Doris Henne-Bruns, K. H. Link, M. Redenbacher, Ludger Staib, Marko Kornmann, W. Baumann, and Silvia Sander. 2006. “24 ORAL Modulation of Adjuvant 5-FU Treatment by Folinic Acid and Interferon-Alpha in Colon and Rectal Cancer: Comparison of Two Phase-III Trials Including 1652 Patients.” European Journal of Surgical Oncology (EJSO) 32 (November): S8–9. doi:10.1016/s0748-7983(06)70459-0.